To investigate the effects of diterpene ginkgolides meglumine on blood homocysteine (Hcy), angiotensin-Ⅱ (Ang-Ⅱ) and neurological function in acute cerebral infarction (CI) patients with CYP2C19 mutation.
A total of 82 acute CI patients with CYP2C19 mutation who were treated in Dalian No.3 people's hospital from January 2018 to April 2020 were selected and divided into the control group (n=41) and the observation group (n=41), using the random number table method. The control group was given aspirin and clopidogrel, and the drug dose was increased. And the observation group was additionally given diterpene ginkgolides meglumine. The platelet function, hemorheology, Hcy, Ang-Ⅱ and nerve function were compared between the two groups before and after treatment.
Before treatment, there were no significant differences in CD62p, CD63 and platelet aggregation rate, hemorheology related, Hcy and Ang-Ⅱ levels, and neurological function-related indexes between the two groups (P>0.05). After treatment, the levels of CD62p, CD63, platelet aggregation rate, hemorheology-related indexes, Hcy and Ang-Ⅱ levels in the observation group were significantly lower than those in the control group (P<0.05), while the levels of brain-derived neurotrophic factor in the observation group were significantly higher than those in the control group (P<0.05). There were statistically significant differences in the above indexes between the observation group and the control group before and after treatment (P<0.05). After treatment, the neuron-specific enolase level and the National Institutes of Health Stroke Scale score were significantly lower than those in the control group (P<0.05), and there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).
Diterpene ginkgolides meglumine can effectively improve platelet function and hemorheological indexes, down regulate the levels of Hcy and Ang-Ⅱ, relieve the symptoms of neurological deficit and improve neurological function in acute CI patients with CYP2C19 mutation.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |